drugset / Trial / NCT01109160

Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation

NCT01109160

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study investigates the role of azithromycin treatment for lymphocytic bronchitis/bronchiolitis after lung transplantation.

Timeline

Start
2010-04
Primary completion
2012-10
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 250 mg